JP7077589B2 - 固形製剤 - Google Patents

固形製剤 Download PDF

Info

Publication number
JP7077589B2
JP7077589B2 JP2017225340A JP2017225340A JP7077589B2 JP 7077589 B2 JP7077589 B2 JP 7077589B2 JP 2017225340 A JP2017225340 A JP 2017225340A JP 2017225340 A JP2017225340 A JP 2017225340A JP 7077589 B2 JP7077589 B2 JP 7077589B2
Authority
JP
Japan
Prior art keywords
mass
salt
tablet
menthol
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017225340A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018090572A5 (enExample
JP2018090572A (ja
Inventor
哲央 小野
亜矢 桑田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of JP2018090572A publication Critical patent/JP2018090572A/ja
Publication of JP2018090572A5 publication Critical patent/JP2018090572A5/ja
Priority to JP2022000850A priority Critical patent/JP7243876B2/ja
Application granted granted Critical
Publication of JP7077589B2 publication Critical patent/JP7077589B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2017225340A 2016-11-29 2017-11-24 固形製剤 Active JP7077589B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022000850A JP7243876B2 (ja) 2016-11-29 2022-01-06 固形製剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016230737 2016-11-29
JP2016230737 2016-11-29

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022000850A Division JP7243876B2 (ja) 2016-11-29 2022-01-06 固形製剤

Publications (3)

Publication Number Publication Date
JP2018090572A JP2018090572A (ja) 2018-06-14
JP2018090572A5 JP2018090572A5 (enExample) 2020-12-24
JP7077589B2 true JP7077589B2 (ja) 2022-05-31

Family

ID=62563583

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017225340A Active JP7077589B2 (ja) 2016-11-29 2017-11-24 固形製剤
JP2022000850A Active JP7243876B2 (ja) 2016-11-29 2022-01-06 固形製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022000850A Active JP7243876B2 (ja) 2016-11-29 2022-01-06 固形製剤

Country Status (1)

Country Link
JP (2) JP7077589B2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019026644A (ja) * 2017-08-01 2019-02-21 ロート製薬株式会社 医薬用錠剤
JP7780242B2 (ja) * 2018-02-26 2025-12-04 ロート製薬株式会社 フェキソフェナジン塩酸塩を含む造粒物
JP7472540B2 (ja) * 2019-03-19 2024-04-23 大正製薬株式会社 固形組成物
JP7667528B2 (ja) * 2020-04-15 2025-04-23 大正製薬株式会社 医薬組成物
JP7709112B2 (ja) * 2020-04-15 2025-07-16 大正製薬株式会社 医薬組成物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000159691A (ja) 1998-09-21 2000-06-13 Taisho Pharmaceut Co Ltd 経口用固形製剤
JP2011148816A (ja) 2005-07-22 2011-08-04 Mitsubishi Tanabe Pharma Corp 口腔内速崩壊性錠
JP2012527406A (ja) 2009-05-20 2012-11-08 リングアル コンセグナ ピーティーワイ エルティーディー 口腔内および／または舌下治療用製剤
JP2014205646A (ja) 2013-04-15 2014-10-30 ロート製薬株式会社 医薬組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9507909A (pt) * 1994-06-03 1997-08-12 Procter & Gamble Formas de dosagem de rápida dissolução
US20140073671A1 (en) * 2011-04-28 2014-03-13 Mitsubishi Tanabe Pharma Corporation Orally disintegrating tablet
JP6062705B2 (ja) * 2012-10-19 2017-01-18 ロート製薬株式会社 医薬組成物
JP6227546B2 (ja) * 2012-10-26 2017-11-08 田辺三菱製薬株式会社 メントールウィスカーの析出を抑制する方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000159691A (ja) 1998-09-21 2000-06-13 Taisho Pharmaceut Co Ltd 経口用固形製剤
JP2011148816A (ja) 2005-07-22 2011-08-04 Mitsubishi Tanabe Pharma Corp 口腔内速崩壊性錠
JP2012527406A (ja) 2009-05-20 2012-11-08 リングアル コンセグナ ピーティーワイ エルティーディー 口腔内および／または舌下治療用製剤
JP2014205646A (ja) 2013-04-15 2014-10-30 ロート製薬株式会社 医薬組成物

Also Published As

Publication number Publication date
JP2022037237A (ja) 2022-03-08
JP2018090572A (ja) 2018-06-14
JP7243876B2 (ja) 2023-03-22

Similar Documents

Publication Publication Date Title
JP7243876B2 (ja) 固形製剤
JP4989733B2 (ja) 口腔内崩壊錠
JP5296456B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP5215172B2 (ja) 乾式直打速崩壊性錠剤
JP7705096B2 (ja) 固形組成物
JP2009544699A (ja) フェニレフリンを含むチュアブル錠
JP2005506987A (ja) 感覚的に許容される口内崩壊性組成物
JP2025100821A (ja) 医薬組成物
JP4965130B2 (ja) 乾式直打速崩壊性錠剤
JP2003034655A (ja) 速崩壊性固形製剤
JP2017141299A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
US9675551B2 (en) Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof
JP2004269513A (ja) 固形製剤
JP6863401B2 (ja) 固形製剤
JP2015110663A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
KR20200131913A (ko) 플루르비프로펜을 포함하는 약학적 조성물
EP2248516A1 (en) Orally disintegrating compositions of emoxypine
JP7067031B2 (ja) 固形製剤
JP2021105057A (ja) 固形製剤
JP4917255B2 (ja) サリチル酸類含有経口組成物
JP5714652B2 (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP5226732B2 (ja) 催眠用圧縮成型製剤
JP2011168615A (ja) サリチル酸類含有経口組成物
JP2021113237A (ja) 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠
JP2013032408A (ja) 口中溶解型又は咀嚼型鼻炎治療用固形内服医薬組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201110

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211109

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220106

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220419

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220502

R150 Certificate of patent or registration of utility model

Ref document number: 7077589

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250